USFDA gives EIR to Alembic for Jorad facility

This was pre-approval inspection to cover Alembic’s solid oral drug products for which ANDAs were filed with USFDA.

231
USFDA Inspection
USFDA Inspection

Last Updated on October 6, 2024 by The Health Master

Alembic Pharmaceuticals has received Establishment Inspection Report (EIR) from US Food and Drug Administration (USFDA) for the inspection carried out at the company’s solid oral formulation facility (F-4) at Jarod, Vadodara during the period from December 8 -16, 2022.

This was pre-approval inspection to cover Alembic’s solid oral drug products for which ANDAs were filed with USFDA.

The company had also started receiving approvals manufactured at this facility. Alembic has a total of five drug product manufacturing facilities and two drug substance manufacturing facilities. All these facilities are inspected and accepted by USFDA.

USFDA issues EIR to Indoco Remedies, Goa

USFDA gives approval for Pupil-dilating spray

USFDA gives approval for this first RSV Vaccine

USFDA gives tentative nod for ARV oral, Dolutegravir

USFDA declines to approve this Hormone Disorder therapy

USFDA issues Form 483 with 3 observation to Zydus, Ahmedabad

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news